 SALT LAKE CITY, June 04, 2021 GLOBE NEWSWIRE -- Paul J. Diaz, president and CEO of Myriad Genetics NASDAQ: MYGN, a leader in genetic testing and precision medicine, will discuss the companys transformation plan and growth initiatives during a fireside chat at the Goldman Sachs 2021 Virtual Global Healthcare Conference at 8:50 a.m. EST on June 10, 2021. 